SMO ClinPlus Co. Ltd.
SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company offers early modeling, preliminary preparation plan trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China.
SMO ClinPlus Co. Ltd. (301257) - Total Liabilities
Latest total liabilities as of June 2025: CN¥247.77 Million CNY
Based on the latest financial reports, SMO ClinPlus Co. Ltd. (301257) has total liabilities worth CN¥247.77 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SMO ClinPlus Co. Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how SMO ClinPlus Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
SMO ClinPlus Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of SMO ClinPlus Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Marcus Corporation
NYSE:MCS
|
USA | $549.96 Million |
|
SK Networks Co Ltd
KO:001740
|
Korea | ₩3.22 Trillion |
|
OPUS GLOBAL Nyrt
BUD:OPUS
|
Hungary | Ft602.11 Billion |
|
Semler Scientific Inc
NASDAQ:SMLR
|
USA | $136.93 Million |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287
|
China | CN¥1.78 Billion |
|
ThredUp Inc
NASDAQ:TDUP
|
USA | $113.40 Million |
|
Hubei Sanxia New Building Materials Co Ltd
SHG:600293
|
China | CN¥1.48 Billion |
|
ZEAL Network SE
XETRA:TIMA
|
Germany | €212.18 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down SMO ClinPlus Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SMO ClinPlus Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SMO ClinPlus Co. Ltd. (2019–2024)
The table below shows the annual total liabilities of SMO ClinPlus Co. Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥256.48 Million | -10.39% |
| 2023-12-31 | CN¥286.22 Million | +37.11% |
| 2022-12-31 | CN¥208.75 Million | +19.01% |
| 2021-12-31 | CN¥175.41 Million | +37.65% |
| 2020-12-31 | CN¥127.43 Million | +66.06% |
| 2019-12-31 | CN¥76.74 Million | -- |